DTRA Researching Hemorrhagic Fever Anti-Viral Compounds

For more on this and other stories, please consider purchasing a membership.
If you are already a subscriber, login to your account.
Ebola patient Significant progress at AVI Biopharma? (Aug 22/10) The Defense Threat Reduction Agency at Fort Belvoir, VA is awarding contracts to find new anti-viral compounds that are effective against hemorrhagic fever viruses, a class that includes Ebola and other diseases. Drug development is a long and expensive process ($100 million is often mentioned as […]

One Source: Hundreds of programs; Thousands of links, photos, and analyses

DII brings a complete collection of articles with original reporting and research, and expert analyses of events to your desktop – no need for multiple modules, or complex subscriptions. All supporting documents, links, & appendices accompany each article.

Benefits

  • Save time
  • Eliminate your blind spots
  • Get the big picture, quickly
  • Keep up with the important facts
  • Stay on top of your projects or your competitors

Features

  • Coverage of procurement and doctrine issues
  • Timeline of past and future program events
  • Comprehensive links to other useful resources